Study reveals nitrosylcobalamin, a modified vitamin B12, penetrates the blood-brain barrier, accumulates in glioblastoma and shows strong anti-tumour activity.

Study reveals nitrosylcobalamin, a modified vitamin B12, penetrates the blood-brain barrier, accumulates in glioblastoma and shows strong anti-tumour activity.

A new experimental treatment may have found a way to outsmart glioblastoma’s toughest defense: the blood-brain barrier. Researchers used sugar-coated nanoparticles to ferry…